APTV vs CUE · P/E 41, rev $19.71B vs rev $9.3M
Aptiv PLC (APTV) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. CUE currently screens at market cap $59.5M.
Not investment advice. Open the APTV and CUE stock pages for the full models.
Not investment advice.